Arcus Biosciences RCUS
NYSE RCUS
$29.65 -0.48 (-1.59%)
As of: Sep 4, 2026 · 3:59 PM EDT

Arcus Biosciences (RCUS) Net Shares Issued and Repurchased (2017 - 2022)

Analysis

Arcus Biosciences (RCUS) Net Shares Issued and Repurchased (2017 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Arcus Biosciences 3.74 Bn 3.04 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 2.30 Mn
Dec 31, 2021 3.76 Mn
Dec 31, 2020 5.78 Mn
Sep 30, 2020 5,000.00
Dec 31, 2019 3.97 Mn
Dec 31, 2018 1.65 Mn
Dec 31, 2017 1.06 Mn